Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders | Zendy

Philip Tarr | Zendy; Patrick Taffé | Zendy; Gabriela Bleiber | Zendy; Hansjakob Furrer | Zendy; Margalida Rotger | Zendy; Raquel Martínez | Zendy; Bernard Hirschel | Zendy; Manuel Battegay | Zendy; Rainer Weber | Zendy; Pietro Vernazza | Zendy; Enos Bernasconi | Zendy; Roger Darioli | Zendy; Martin Rickenbach | Zendy; Bruno Ledergerber | Zendy; Amalio Telenti | Zendy

Open Access

Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders

Author(s) -

Philip Tarr,

Patrick Taffé,

Gabriela Bleiber,

Hansjakob Furrer,

Margalida Rotger,

Raquel Martínez,

Bernard Hirschel,

Manuel Battegay,

Rainer Weber,

Pietro Vernazza,

Enos Bernasconi,

Roger Darioli,

Martin Rickenbach,

Bruno Ledergerber,

Amalio Telenti

Publication year - 2005

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/429295

Subject(s) - hypertriglyceridemia , lipoatrophy , lipodystrophy , triglyceride , apolipoprotein e , medicine , dyslipidemia , endocrinology , hyperlipidemia , ritonavir , genotype , lipid profile , cholesterol , biology , genetics , viral load , antiretroviral therapy , immunology , diabetes mellitus , human immunodeficiency virus (hiv) , obesity , disease , gene

Single-nucleotide polymorphisms in genes involved in lipoprotein and adipocyte metabolism may explain why dyslipidemia and lipoatrophy occur in some but not all antiretroviral therapy (ART)-treated individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research